Two new antitumour drugs, imide derivatives of 3-nitro-l, 8-naphthalic acid having different basic side chains linked to the imide nitrogen, have been shown to bind to double-helical D NA by intercalation. At ionic strength 0.01 mol/litre, pH 7, their intrinsic association constants are about 1.45 x 10 M~l and each bound ligand molecule occludes about 3.4 nucleotides of the DNA lattice. They remove and reverse the supercoiling of closed circular duplex PM2 DNA with apparent unwinding angles of 11-12° per bound drug molecule, referred to an assumed unwinding angle of 26° for ethidium. They increase the viscosity of sonicated rod-like DNA fragments, each bound drug molecule producing a calculated increment in length of 2.2 -2.5 A. No important differences between the DNA-binding characteristics of the two drugs were detected, though one appears marginally more active than the other in certain biological tests.
INTRODUCTION
Mechanisms of drug binding to DNA attract a good deal of current interest in molecular biology and medicinal chemistry (1) (2) (3) (4) .
An understanding of the precise nature of drug-DNA complexes is considered important for two principal purposes: firstly as a means of explaining the molecular basis of action of chemotherapeutic agents which are believed to owe their selectivity and/or biological effect to interaction(s) at this level; and secondly in monitoring possible toxic, mutagenic, or carcinogenic consequences of exposure to drugs, environmental contaminants, and so on. This paper concerns a study within the former category, i.e. an attempt to elucidate the molecular basis of action of a new series of antitumour agents.
The drugs in question were synthesised as part of a programme aimed at combining the known antitumour activity of compounds containing a P-nitronaphthalene moiety, as occurs naturally in aristolochic acid (5, 6) , with other structural entities suspected to be potentially efficacious such as a glutarimide ring and a positively charged tertiary amine side-chain (7, 8) .
Two compounds which originated in this way, code named M-12210 and M-4212 (the latter designated mitonafide by the World Health Organisation) proved particularly active against experimental tumours and several cell lines in vitro (7, 8) and have been shown to be selective inhibitors of nucleic acid synthesis in Ehrlich ascites tumour cells (8) . Their (9), chloroquine (10) (11) (12) , quinine (13) and
M-12210
ChL-CH,,-NH \ CH. 
MATERIALS AND METHODS
M-4212 and M-12210 were synthesised, purified and characterised as reported elsewhere (7, 8) . The buffer used throughout (designated 0.01 SHE) contained 2 mM HEPES, 10 pM EDTA, and 9.4 mM NaCl dissolved in glass-distilled water; it was adjusted with NaOH to pH 7.0 at 20 C, giving a resultant ionic strength of 0.01 mol/litre. Drug solutions were always freshly prepared by triturating a few mg of the compound (supplied as the free base) with 0.01 SHE buffer, filtering through two Whatman GF/C glass fibre filters and finally clarifying completely by centrifugation at 5 000 x g for 10 min. The concentration in the supernatant was determined from measurements of the absorbance at 334 nra for M-4212 (E.,. = 8240 based on a formula weight of 313) and at 335 nm for M-12210 (E,-,. = 8475 based on a formula weight of 339). Stock solutions thus prepared were generally a little less than 1 mM; they were maintained in the dark at room temperature, used to form complexes as promptly as possible, and every effort was made to avoid exposure of experimental solutions to light. nm with respect to nucleotides) of 6600.
Absorption spectra were recorded on a Beckman Acta C III double-beam spectrophotometer with 10 mm light path quartz cuvettes. and c (the free drug concentration) and expressed in the form of Scatchard plots (21) which were analysed in terms of equation (10) of McGhee and Von Hippel (22):
In this equation the intrinsic association constant for binding to an isolated site K(O) is given by the intercept on the ordinate (r/c axis) of a Scatchard plot and Q, the parameter of apparent site-size, represents the number of nucleotides occluded by the binding of a single ligand molecule. Computations were performed as previously described (17).
Sedimentation coefficients were determined by boundary sedimentation at 34 000 rev/min in a Beckman model E analytical ultracentrifuge equipped with u.v. optics and photoelectric scanner according to standard procedures (11). They are presented in the form ^Q, determined directly at 20 C and uncorrected for viscosity, buoyancy or DNA concentration. Drug-PM2 DNA complexes were formed by method 2 of Waring (ll) in which samples may be re-run after addition of fresh increments of drug.
Viscometric experiments were conducted as previously described (17,23) generalised broadening with loss of the shoulders at approx. 320 and 370 nm present in the spectrum of the free drug. The hypochromism, however, is substantial: a 49% reduction occurs in the absorbance at the peak maximum in the presence of excess DNA. More importantly, when the drug/nucleotide ratio is such that only a fraction of the ligand is bound the measured spectra pass clearly through an isosbestic point at 374 nm. This is presumptive evidence that such intermediate spectra represent the sum of contributions from two species of drug -free and bound -and that they may be used to estimate the fraction of the drug in the DNA-bound state by simple proportionality (1, 19, 20) .
Similar behaviour was observed with M-12210. For the determination of binding isotherms the peak wavelength of the free drug (335 nm) was chosen, being the wavelength at which the largest change in extinction coefficient occurs on binding to the polymer.
Scatchard plots determined by this means are presented in (24) and the value of a, the site-size parameter, approaches 4 as predicted for intercalating drugs subject to the phenomenon of neighbour exclusion in their interaction with DNA (22,25). Interaction with closed circular duplex DNA. In Figure 4 it can be seen that both drugs promote removal and reversal of the supercoiling of covalently closed circular DNA in the fashion characteristic of intercalating agents (1, 11, 12) . At the same time they cause the usual small, monotonic decrease in S_. of the nicked circular DNA molecules also characteristic of intercalative binding.
The equivalence ratios (11) corresponding to exact relaxation of the supercoiling of the closed circles are 0.14 + 0.03 and 0.13 + 0.03 for M-4212 and M-12210 respectively. Granted that the data points are (unaccountably) more scattered for M-12210 than for M-4212 it is dubious whether there is any significant difference between the effects of the two drugs, as the overlap in the estimates of error would imply.
These numbers can be converted to true equivalence binding ratios and (24) and is probably a good deal higher than that for binding of chloroquine to DNA (35). Since the two-ring nitronaphthalene chromophore of the present drugs might reasonably be considered more akin to the quinoline nucleus of chloroquine than to the three-ring phenanthridine system this result may appear surprising.
In respect of their helix-unwinding angles the drugs fall at the low-angle end of the range thus far determined for intercalating agents.
In fact, the values of 11.2 and 12.1 are very close to those reported for the antitumour antibiotics daunomycin (11) and adriamycin (12), corrected to the new reference (27,28) of 26° for ethidium, i.e.
11.3 and 11.5 respectively. Again there seems to be a significant difference from chloroquine, which was calculated to have much the same unwinding angle as ethidium (subject to a large margin of error (12)), but the lack of any obvious correlation between the unwinding angles associated with intercalative binding of drugs having differently sized homologous and non-homologous chromophores has been noted before (11, 12, 24) . 
